Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 19/20 | 0.84 |
| ▸ | VEGFA | P15692 | 3/20 | 0.60 |
| ▸ | FLT1 | P17948 | 3/20 | 0.60 |
| ▸ | EGLN3 | Q9H6Z9 | 2/20 | 0.60 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19808937 | 0.91 | EGLN1 (1.00) | EGLN1VEGFAFLT1EGLN3FTO | |
| SCHEMBL20117505 | 0.87 | EGLN1 (0.77) | EGLN1VEGFAFLT1EGLN3FTO | |
| SCHEMBL20117504 | 0.84 | EGLN1 (0.72) | EGLN1VEGFAFLT1EGLN3FTO | |
| SCHEMBL19808950 | 0.83 | EGLN1 (0.72) | EGLN1VEGFAFLT1EGLN3 | |
| SCHEMBL19823643 | 0.83 | EGLN1 (0.78) | EGLN1VEGFAFLT1EGLN3FTO | |
| SCHEMBL20117507 | 0.81 | EGLN1 (0.80) | EGLN1EGLN3FTO | |
| SCHEMBL20117488 | 0.80 | EGLN1 (0.73) | EGLN1VEGFAFLT1EGLN3FTO | |
| SCHEMBL19808953 | 0.80 | EGLN1 (1.00) | EGLN1VEGFAFLT1EGLN3FTO | |
| SCHEMBL20117478 | 0.79 | EGLN1 (0.80) | EGLN1VEGFAFLT1EGLN3FTO | |
| SCHEMBL20117494 | 0.79 | EGLN1 (0.68) | EGLN1VEGFAFLT1EGLN3FTO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180117021-A1 | COMPOUND OF 3-HYDROXYL PYRIDINE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE THEREOF | SHENYANG SUNSHINE PHARMACEUTICAL CO., LTD. (CN) | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180117021-A1 | COMPOUND OF 3-HYDROXYL PYRIDINE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE THEREOF | EGLN3, EGLN2, P4HA1 | EGLN1 6/4885VEGFA 170/4885FLT1 285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.